Rubato, founded with the mission to revolutionize music therapy for seniors suffering from dementia and cognitive impairment, leverages AI-powered, biometrical personalized interventions. The company offers a non-drug, data-driven solution to manage agitation and other behavioral disturbances through personalized music therapy. Utilizing standard wearables and Spotify, Rubato's machine learning algorithm identifies the musical attributes that elicit specific biological responses in each listener, tailoring the therapy to individual needs.
Notable affiliated individuals and investors include experts in AI, healthcare, and music therapy, though specific names are not provided. Key achievements include the development of a sophisticated algorithm capable of personalizing music therapy based on biometric data. Rubato's impact lies in its innovative approach to improving the quality of life for seniors with cognitive impairments, offering a scalable and effective alternative to traditional drug-based treatments.
Quick Facts
When was Rubato's last funding round?
Rubato's most recent funding round was for $20k (USD) in March 2024.
How much disclosed funding has Rubato raised?
As of Mar 11, 2024, Rubato has disclosed funding of $20k (USD).